Skip to content

Efficacy of kinesiotape in facial muscle pain.

Evaluation of efficacy of kinesiotape as first line therapy in myofascial masticatory pain. - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081660
Enrollment
70
Registered
2025-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M628- Other specified disorders of muscle

Interventions

Intervention1: KINESIOLOGY TAPE: TWO APPLICATIONS OF KINESIOLOGY TAPE WILL BE APPLIED TO MASSETER MUSCLE FOR 3 DAYS EACH FOR ONE WEEK Control Intervention1: NSAIDS AND MUSCLE RELAXANT: NSAIDS AND MUSC

Sponsors

PGIDS ROHTAK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with Myofascial masticatory pain according to recent RDC Criteria. 2. Patients consent for participation in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with history of trauma in temporomandibular joint. 2 Patients having any developmental anomaly related to TMJ. 3 Patients having history of TMJ arthralgia. 4 Patients having pregnancy, asthma or any psychiatric disorder ,rheumatoid arthritis , gastric or duodenal ulcer etc. 5 Known tolerance/allergy to study drug. 6 Noncompliant during screening period. 7 Pain attributable to recent facial trauma, dental surgery or placement of a dental appliance. 8 Allergy to tape, open wounds ,acne or skin infection or skin disease in area of application. 9 Patient with fibromyalgia 10 Patient taking analgesics or muscle relaxant regularly for any indication.

Design outcomes

Primary

MeasureTime frame
VAS assessment of pain.Timepoint: Baseline, 1st week, 2nd week and 4th week

Secondary

MeasureTime frame
To evaluate the change in masticatory efficiency in both groups. To evaluate the treatment satisfaction in both groups. Adverse side effects associated with treatment in both groups. To evaluate changes in pain related disability and functional limitation Timepoint: One year

Countries

India

Contacts

Public ContactPushpa

PGIDS ROHTAK

Aryalavina@gmail.com8168233314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026